← Back to Search

Genetic Testing

Genetic Testing for Hereditary Cancer Risk

N/A

Recruiting

Led By Arun Banu, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion; an average of 1 year.

Awards & highlights

Study Summary

This trial offers genetic testing and screening for women at risk for hereditary cancer to help prevent, detect, and personalize treatment.

Who is the study for?

This trial is for women scheduled for mammograms with Project VALET's mobile units. It aims to identify those at risk of hereditary cancers like ovarian, breast, and colorectal cancer by providing genetic screening and counseling.Check my eligibility

What is being tested?

The study tests the effectiveness of using mobile mammography units to offer genetic testing and counseling services. The goal is to see if this approach helps in early detection or personalized treatment planning for hereditary cancers.See study design

What are the potential side effects?

Since the interventions involve non-invasive procedures like genetic testing and counseling, there are minimal physical side effects expected. However, participants may experience emotional or psychological impacts from learning about their cancer risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion; an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion; an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Screening FormExperimental Treatment1 Intervention

Participants will complete a screening form to assess your risk of hereditary breast and colorectal cancers.

Group II: Genetic Testing and CounselingExperimental Treatment1 Intervention

Participants will be given a saliva collection kit to collect a saliva sample for hereditary cancer and genetic testing. The kit includes all standard paperwork and instructions for collecting the sample and shipping the kit back to the genetic testing company (Invitae).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,788,476 Total Patients Enrolled

147 Trials studying Breast Cancer

62,286 Patients Enrolled for Breast Cancer

Community Outreach and Engagement Fund for Underserved TexansUNKNOWN

Arun Banu, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Genetic Testing and Counseling (Genetic Testing) Clinical Trial Eligibility Overview. Trial Name: NCT05649072 — N/A

Breast Cancer Research Study Groups: Genetic Testing and Counseling, Screening Form

Breast Cancer Clinical Trial 2023: Genetic Testing and Counseling Highlights & Side Effects. Trial Name: NCT05649072 — N/A

Genetic Testing and Counseling (Genetic Testing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05649072 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to partake in this medical experiment?

"Indeed, records on clinicaltrials.gov verify that this investigation is currently recruiting subjects. This trial was originally posted in November 18th 2022 and edited most recently on June 6th 2023. The study necessitates 1000 participants to be sourced from 1 medical hub."

Answered by AI

How many persons have enrolled in this experiment?

"Yes, clinicaltrials.gov verifies that this trial is actively searching for volunteers; it was originally published on November 18th 2022 and most recently updated on June 6th 2023. The study needs to recruit 1000 individuals from 1 medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

2022. "Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05649072.

All > Hereditary Angioedema